Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
NLY heads into its October 20 print with the stock down 15% over the past month to $18.23, trading well below the Street's average price target.
The most striking feature of the setup is how aggressively analysts have trimmed their targets while keeping positive ratings. Piper Sandler cut its target from $25 to $21.50 on October 9, and BTIG followed two days earlier, moving from $24 to $21. Both firms held constructive ratings. That pattern, target reductions without downgrades, points to a Street that still sees value at current levels but is acknowledging that near-term conditions have deteriorated. The consensus mean target now sits at $22.63, implying roughly 24% upside from Friday's close. The price-to-book ratio has fallen to 0.92 over the past month, a meaningful compression, and the stock now trades below book value, a level that historically draws income-focused buyers into mortgage REITs. EPS surprise ranks in the 88th percentile across the ORTEX universe, a genuine positive for bulls who believe the company can beat again.
Bears focus on a more structural concern. Book value fell 1.9% sequentially last quarter to $19.82, dragged by $672 million of fair value losses on investments. GAAP EPS of $0.33 came in well below expectations. The net interest spread narrowed to 142 basis points as the portfolio rotated into lower coupons, and the company carries heavy leverage concentrated in agency MBS. That leaves earnings vulnerable to funding cost moves, prepayment surprises, and any policy shift affecting the GSE-backed market. Bulls counter that earnings available for distribution of $0.76 per share covered the dividend for the tenth consecutive quarter, and that mid-teen new-money returns on equity with $9 billion of financing capacity give the company room to rotate toward higher-returning assets. The forward earnings revision picture is less encouraging: the 12-month forward EPS growth score ranks in just the 8th percentile, suggesting consensus still sees earnings under pressure.
Options positioning tells a contrarian story relative to the stock's recent weakness. The put/call ratio has dropped to 0.96, nearly two standard deviations below its 20-day average of 1.12, and well off its 52-week high of 1.24. That is a notably lighter-than-usual tilt toward downside hedges for a stock that has lost 15% in a month. It may reflect income investors rolling out of puts after the decline, or a view that the worst of the rate-driven mark-to-market pressure is priced in. Short interest reinforces this picture. At 3.3% of the free float, it has risen about 31% over the past month in share terms, but borrowing costs remain low at 0.42% and availability is loose at 750%, meaning there is no meaningful squeeze dynamic or unusual borrow demand in the lending market.
BlackRock added over 5 million shares in the most recent reporting period, lifting its stake to 11.6% of shares outstanding, a notable increase from one of the largest passive holders. The most recent open-market insider activity is less constructive: CEO David Finkelstein sold 50,000 shares in August under a pre-arranged 10b5-1 plan, a mechanical rather than discretionary transaction, but the net insider picture over the past 90 days is modestly negative.
Monday's print will test whether book value has stabilised after the September quarter's rate moves, and whether EAD can continue to cover the dividend at a level that justifies buying a mortgage REIT at a discount to book.
See the live data behind this article on ORTEX.
Open NLY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
